InvestorsHub Logo
Followers 77
Posts 2758
Boards Moderated 0
Alias Born 11/16/2012

Re: None

Thursday, 11/24/2016 6:23:52 AM

Thursday, November 24, 2016 6:23:52 AM

Post# of 194795
Update from the President November 22, 2016


Dear Shareholders,
We are pleased to announce that we are in the final phase of completion with FINRA/SEC compliance. We are looking forward to Creative Edge Nutrition’s OTC market status to be reinstated very soon. Our CPA has been working diligently to bring our Financial Statements current, and will start posting on OTC Pink in the upcoming week upon final review.

The anticipation to launch Giddy Up Energy Products has been extraordinary to say the least. The unforeseen challenges, obstacles and adversities, which has been under the telescope long before I came onboard, has contributed to the delays in reinstatement of FITX, as well as, the imminent launch of Giddy Up first (1st) two (2) products. I understand that this action has brought about many concerns from you our Shareholders; however, although there have been many inquiries on the internet about Creative Edge Nutrition, I can assure you there is a silver lining beneath the seemingly dark cloud and the future is very bright.

In addition, I realize there has been two (2) past statements released that were made by me projecting status and launch of the anticipated Giddy Up Energy Products, that has not manifested. Therefore, I will give you all an update after the Thanksgiving holidays of a more accurate production schedule and launch projection of Giddy Up products’ to the market.

I want to personally express my appreciation and gratitude to all of our FITX Shareholders for their continuous unwavering support and patience since my tenure as President/CEO. The one thing I can say unequivocally is that Giddy Up is real! Giddy Up will launch! And has a great future coming 2017 and beyond.

James L. Robinson
President-CEO
Creative Edge Nutrition, Inc.

http://www.drinkgiddyup.com/press.php

With knowledge comes the freedom to choose.